About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports First Quarter 2021 Financial Results 05-05-2021 at 4:05 PM EDT Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference 04-27-2021 at 4:05 PM EDT Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021 04-12-2021 at 4:05 PM EDT VIEW ALL NEWS Upcoming Events & Presentations Adaptive Biotechnologies at the BofA Securities 2021 Healthcare Conference May 11, 2021 at 8:45 AM PDT Add to Outlook Add to Google Calendar Listen to webcast Past Events & Presentations Adaptive Biotechnologies First Quarter Financial Results May 5, 2021 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies First Quarter Earnings Presentation 1.3 MB Cowen 41st Annual Health Care Conference Mar 2, 2021 at 10:30 AM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter Financial Results Feb 24, 2021 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter and FY 2020 Earning Conference Call 1.3 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP May 11, 2021 8:52 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
